P1231: IMPACT OF ARID1A AND TP53 MUTATIONS IN PEDIATRIC REFRACTORY OR RELAPSED MATURE B-CELL LYMPHOMA TREATED WITH CAR-T CELL THERAPY

• Qinlong Zheng,
• Yang LI,
• Yang Liu,
• Keyan Yang,
• Ling Jin,
• Jing Yang,
• Shuang Huang,
• Ying Liu,
• Rong Liu,
• Wei Liu,
• Ansheng Liu,
• Yonghong Zhang

Affiliations

Qinlong Zheng

1 Beijing GoBroad Boren Hospital, Medical Laboratory, Beijing, China

Yang LI

1 Beijing GoBroad Boren Hospital, Medical Laboratory, Beijing, China

Yang Liu

2 Beijing GoBroad Boren Hospital, Department of Pediatric Lymphoma, Beijing, China

Keyan Yang

1 Beijing GoBroad Boren Hospital, Medical Laboratory, Beijing, China

Ling Jin

3 National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University, Department of Hematology/Oncology, Beijing, China

Jing Yang

3 National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University, Department of Hematology/Oncology, Beijing, China

Shuang Huang

3 National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University, Department of Hematology/Oncology, Beijing, China

Ying Liu

2 Beijing GoBroad Boren Hospital, Department of Pediatric Lymphoma, Beijing, China

Rong Liu

4 Capital institute of pediatric, Department of Hematology/Oncology, Beijing, China

Wei Liu

5 Zhengzhou Children’s Hospital, Department of Hematology/Oncology, Zhengzhou, China

Ansheng Liu

6 Xi’an Children’s Hospital, Department of Hematology/Oncology, Xi’An, China

Yonghong Zhang

2 Beijing GoBroad Boren Hospital, Department of Pediatric Lymphoma, Beijing, China